Dr. Grimm is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4405 Weaver Pkwy
Warrenville, IL 60555Phone+1 630-352-5450- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2001 - 2005
- The University of Texas Health Science Center at San AntonioClass of 2001
Certifications & Licensure
- IL State Medical License 2007 - 2026
- MN State Medical License 2012 - 2013
- NY State Medical License 2002 - 2007
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Feb 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsA multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.Priya Kumthekar, Sean Aaron Grimm, Marc C Chamberlain, David Schiff, Patrick Y Wen, Fabio Massaiti Iwamoto, Demirkan Besim Gursel, David A Reardon, Benjamin Purow, Mas...> ;Neuro-Oncology Advances. 2022 Aug 19
- 22 citationsA phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, effic...Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee, Sean A Grimm, Margaret Schwartz, Kirsten L Bell Burdett, Rimas V Lukas, Karan Dixit, Is...> ;Neuro-Oncology. 2023 Mar 14
- Secondary CNS myeloma with remission after systemic CNS-penetrating agents.Luis G Fernandez 3rd, Daniel Eduardo Oyon, Vinai Gondi, Sean Grimm, Osaama H Khan> ;Neuro-Oncology Advances. 2022 Jul 1
- Join now to see all
Press Mentions
- 5 Facts You May Not Know About Brain TumorsNovember 15th, 2022
Hospital Affiliations
- Rush University Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: